Turku Bioscience Centre
Persons
Publications
- An unbiased in vitro screen for activating epidermal growth factor receptor mutations (2019)
- A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-2a as first line treatment in metastatic melanoma (2010)
- A pH-Responsive Cluster Metal-Organic Framework Nanoparticle for Enhanced Tumor Accumulation and Antitumor Effect (2022)
- A pH/temperature responsive nanocomposite for chemo-photothermal synergistic cancer therapy (2023)
- A Plasmid-Based Fluorescence Reporter System for Monitoring Oxidative Damage in E. coli (2022)





